Gene · 3660
Papers2,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation and Immunotherapeutic Targeting of the Epigenome in Exhausted CD8 T Cell Responses. | J Immunol | 2023 | 36947818 | PubTator, text mining | PubMed |
| Basal and immune-responsive transcript expression of two Atlantic salmon interferon regulatory factor 2 (irf2) paralogues. | Dev Comp Immunol | 2023 | 36934886 | PubTator, text mining | PubMed |
| MicroRNAs in cancer metastasis: biological and therapeutic implications. | Expert Rev Mol Med | 2023 | 36927814 | PubTator, text mining | PubMed |
| Identification of immune-related hub genes and analysis of infiltrated immune cells of idiopathic pulmonary artery hypertension. | Front Cardiovasc Med | 2023 | 36926043 | PubTator, text mining | PubMed |
| Differential expression of pyroptosis-related genes in the hippocampus of patients with Alzheimer's disease. | BMC Med Genomics | 2023 | 36918839 | PubTator, text mining | PubMed |
| Emerging role of miRNAs, lncRNAs, and circRNAs in pregnancy-associated diseases. | Chin Med J (Engl) | 2023 | 36914956 | PubTator, text mining | PubMed |
| Potential of Circulating miRNAs as Molecular Markers in Mood Disorders and Associated Suicidal Behavior. | Int J Mol Sci | 2023 | 36902096 | PubTator, text mining | PubMed |
| Exosomes in Colorectal Cancer: From Physiology to Clinical Applications. | Int J Mol Sci | 2023 | 36901813 | PubTator, text mining | PubMed |
| Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics. | Cells | 2023 | 36899946 | PubTator, text mining | PubMed |
| An Emerging Role for Type I Interferons as Critical Regulators of Blood Coagulation. | Cells | 2023 | 36899914 | PubTator, text mining | PubMed |
| Identifying key transcription factors and miRNAs coregulatory networks associated with immune infiltrations and drug interactions in idiopathic pulmonary arterial hypertension. | Math Biosci Eng | 2023 | 36899621 | PubTator, text mining | PubMed |
| Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity. | Nat Cancer | 2023 | 36894639 | PubTator, text mining | PubMed |
| Editorial: Women in NK and innate lymphoid cell biology. | Front Immunol | 2023 | 36875138 | PubTator, text mining | PubMed |
| Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology. | Front Pharmacol | 2023 | 36874011 | PubTator, text mining | PubMed |
| TP63 Functions as a Tumor Suppressor Regulated by GAS5/miR-221-3p Signaling Axis in Human Non-Small Cell Lung Cancer Cells. | Cancer Manag Res | 2023 | 36873253 | PubTator, text mining | PubMed |
| TRIM56 acts through the IQGAP1-CDC42 signaling axis to promote glioma cell migration and invasion. | Cell Death Dis | 2023 | 36870986 | PubTator, text mining | PubMed |
| A new immune checkpoint-associated nine-gene signature for prognostic prediction of glioblastoma. | Medicine (Baltimore) | 2023 | 36862886 | PubTator, text mining | PubMed |
| Interferon regulatory factor 1 (IRF1) inhibits lung endothelial regeneration following inflammation-induced acute lung injury. | Clin Sci (Lond) | 2023 | 36857175 | PubTator, text mining | PubMed |
| Tumour‑derived exosomes and their emerging roles in leukaemia (Review). | Exp Ther Med | 2023 | 36845960 | PubTator, text mining | PubMed |
| Pharmacogenetic Analysis of the MIR146A rs2910164 and MIR155 rs767649 Polymorphisms and Response to Anti-TNF Treatment in Patients with Crohn's Disease and Psoriasis. | Genes (Basel) | 2023 | 36833372 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3660/papers?page=15